Drug profile · INN
methyclothiazide
METHYCLOTHIAZIDE
methyclothiazide (METHYCLOTHIAZIDE) is a thiazide-sensitive sodium-chloride cotransporter inhibitor. Route of administration: oral. Current US regulatory status: approved.
Drug details — methyclothiazide
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 1
- Programs
- 0
- Data quality
- 0.84
Quick answer
methyclothiazide (METHYCLOTHIAZIDE) is a thiazide-sensitive sodium-chloride cotransporter inhibitor. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Thiazide-sensitive sodium-chloride cotransporter inhibitor
Primary target: Solute carrier family 12 member 3
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Related patents
Frequently asked questions
What is methyclothiazide?
methyclothiazide (METHYCLOTHIAZIDE) is a thiazide-sensitive sodium-chloride cotransporter inhibitor. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for methyclothiazide?
METHYCLOTHIAZIDE is a marketed brand name for methyclothiazide. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of methyclothiazide?
methyclothiazide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.